Ouvrages publiés en collaboration (1)
  1. 1. Vereecken, P., & Awada, A. (2012). Handbook of skin care in cancer patients.
    2.   Parties d'ouvrages collectifs (11)
  2. 1. Costante, G., Lalami, Y., Jungels, C., & Awada, A. (2018). Calcitonin and Carcinoembryonic Antigen for the Diagnosis and Management of Medullary Thyroid Carcinoma. In L. Giovanella (Ed.), Atlas of Thyroid and Neuroendocrine Tumor Markers (pp. 133-150). Springer, Cham. doi:10.1007/978-3-319-62506-5_9
  3. 2. Thomas, F., & Awada, A. (2015). Utility of next-generation sequencing in cancer drug development and clinical trials. In Next Generation Sequencing in Cancer Research, Volume 2: From Basepairs to Bedsides (pp. 19-38). Springer International Publishing. doi:10.1007/978-3-319-15811-2_2
  4. 3. Aftimos, P., Gombos, A., Pugliano, L., Awada, A., & Piccart-Gebhart, M. (2013). Breast Cancer. In M.-A. Dicato (Ed.), Side Effects of Medical Cancer Therapy: Prevention and Treatment (pp. 29-117). London Heidelberg New York Dordrecht: Springer. doi:10.1007/978-0-85729-787-7_2
  5. 4. Prenen, H., & Awada, A. (2008). A critical review of cutaneous toxicity of anticancer treatments. In Handbook of Skin care in cancer patients.
  6. 5. Bernard, C., Awada, A., D'Hondt, V., & Piccart-Gebhart, M. (2007). Thérapie ciblée et cancer du sein. In M. Espié & A. Gorins (Eds.), Le Sein: Du normal au pathologique : Etat de l’art (3 ed., pp. 1013-1031). France: ESKA.
  7. 6. Bernard, C., Mancini, I., Cardoso, F., Sotiriou, C., D'Hondt, V., Awada, A., & Piccart-Gebhart, M. (2005). Traitement systèmatique du cancer du sein métastatique: état des connaissances. In Cancer du sein: nouvelles approches diagnostiques et thérapeutiques (pp. 205-225). Boulogne: GSP.(Référencees en gynécologie obstétrique).
  8. 7. Piccart-Gebhart, M., Cardoso, F., Awada, A., Di Leo, A., & Gelber, R. (2002). Kontroversen in der adjuvanten systemischen Therapie des rezeptornegativen Mammakarcinoms. In M. Untsch, H. Sittek, I. Bauerfeind, G. Konecny, M. Reiser, & H. Hepp (Eds.), Diagnostik und Therapie des Mammarkarzinoms: State of the Art. Munchen-Wien-New York: W. Zuckschwerdt Verlag.
  9. 8. Awada, A., & Piccart-Gebhart, M. (2002). Antimicrotubule agents. In J. Cassidy, D. Bisset, & R. A. J. Spence (Eds.), Oxford Handbook of Oncology. Oxford University Press.
  10. 9. de Valeriola, D., Awada, A., Roy, J. A., Di Leo, A., Biganzoli, L., & Piccart-Gebhart, M. (2000). Breast cancer therapies in development: A review of their pharmacology and clinical potential. In Breast Cancer Management (pp. 35-72). Wiseman.
  11. 10. Cornez, N., Awada, A., & Piccart-Gebhart, M. (1999). Practical guide to chemotherapy and hormonal therapy administration for physicians and nurses. In Supportive Care in Cancer: A Handbook for Oncologists (pp. 579-614). CRC Press.
  12. 11. Piccart-Gebhart, M., Di Leo, A., Awada, A., & de Valeriola, D. (1996). Docetaxel in the treatment of breast cancer : current status, ongoing trials and future directions. In Breast Cancer: Advances in biology and therapeutics (pp. 257-264).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>